Bruce Warshauer, MD
Dermatology · Point Pleasant, NJNPI 1831112689
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $635 of the $815 with a category attached, or 77.9%. 10 manufacturers reported payments, led by Johnson & Johnson at 53.0% of the total. Reporting peaked in 2024 at $216 and has fallen 59.8% since, to $87 in 2025. That places this record below the midpoint for dermatology clinicians in NJ, where the typical reported total is $1,986.
Across 38 payments — averaging $21.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$432
- Sanofi$165
- AbbVie$90
- Biofrontera Inc.$31
- LEO Pharma Inc.$25
- Incyte Corporation$22
- plus $49 from 4 others
What the payments were for
- Food & beverage$63578%
- Education$18022%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 19 | $432 |
| Sanofi | 3 | $165 |
| AbbVie | 6 | $90 |
| Biofrontera Inc. | 3 | $31 |
| LEO Pharma Inc. | 2 | $25 |
| Incyte Corporation | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $14 |
| Novartis | 1 | $13 |
| UCB, Inc. | 1 | $12 |
| Sun Pharmaceutical Industries Inc. | 1 | $11 |
How this compares
$815 in reported general payments places this provider in the 30th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $93,389 |
| Imiquimod | 209 | $4,495 |
| Gentamicin Sulfate | 124 | $3,297 |
| Betamethasone Valerate | 40 | $1,348 |
| Calcipotriene | 15 | $964 |
| Metronidazole | 12 | $934 |
| Mupirocin | 124 | $756 |
| Fluocinonide | 20 | $608 |
| Ketoconazole | 24 | $421 |
| Mometasone Furoate | 27 | $307 |
| Econazole Nitrate | 26 | $302 |
| Triamcinolone Acetonide | 37 | $258 |
| Nystatin | 26 | $212 |
| Hydrocortisone | 11 | $211 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Point Pleasant
- Omar NoorSomerset$4.5M
- Linda Cappiello-LindsleyHoboken$2.3M
- Brian KeeganEast Windsor$1.7M
- Jerry BagelEast Windsor$1.6M
- Mital Patel CohenFlorham Park$799K
- Ronald BernardinVoorhees$688K
- Brian MachlerFlorham Park$346K
- Jeanine DownieMontclair$327K
- Aanand GeriaRutherford$251K
- Jason MillerFreehold$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.